Vertex Pharmaceuticals Incorporated (VRTX) — Stock Price, Chart & Analysis
Vertex Pharmaceuticals Incorporated (VRTX) is a Healthcare stock currently trading at $496.07, up 2.49% on the day. It carries a market capitalization of $125.73B and a trailing P/E ratio of 28.17. Over the past 52 weeks, VRTX has traded between $362.50 and $533.67. Vertex Pharmaceuticals Incorporated does not currently pay a regular dividend. View the live VRTX chart, technical opinion, analyst ratings, fundamentals and latest news below.
Vertex Pharmaceuticals Incorporated (VRTX) key data
| Price | $496.07 |
| Change (today) | +2.49% |
| Previous close | $484.03 |
| Market cap | $125.73B |
| P/E ratio (TTM) | 28.17 |
| EPS (TTM) | $17.61 |
| 52-week high | $533.67 |
| 52-week low | $362.50 |
| Beta | 0.30 |
| Avg. volume | 1.56M |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently asked questions about Vertex Pharmaceuticals Incorporated (VRTX)
How much does one share of Vertex Pharmaceuticals Incorporated cost?
As of the latest update, one share of Vertex Pharmaceuticals Incorporated (VRTX) trades at $496.07 (+2.49% today).
What is Vertex Pharmaceuticals Incorporated's market cap?
Vertex Pharmaceuticals Incorporated has a market capitalization of approximately $125.73B.
What is Vertex Pharmaceuticals Incorporated's P/E ratio?
Vertex Pharmaceuticals Incorporated has a trailing price-to-earnings (P/E) ratio of 28.17.
What is Vertex Pharmaceuticals Incorporated's earnings per share (EPS)?
Vertex Pharmaceuticals Incorporated's trailing twelve-month EPS is $17.61.
Does Vertex Pharmaceuticals Incorporated pay a dividend?
Vertex Pharmaceuticals Incorporated does not currently pay a regular dividend.
What is Vertex Pharmaceuticals Incorporated's 52-week trading range?
Over the past year, VRTX has traded between $362.50 and $533.67.
What is the analyst price target for Vertex Pharmaceuticals Incorporated?
The mean analyst price target for Vertex Pharmaceuticals Incorporated is $559.28. This is informational only and not investment advice.
Latest Vertex Pharmaceuticals Incorporated (VRTX) news
- Could 1 Tiny Biotech Topple Vertex Pharmaceuticals' Cystic Fibrosis Empire?News · Aug 7, 2026
- What Insmed Stock's Premium Is Actually BuyingNews · Aug 7, 2026
- Vortex Energy Receives Final Technical Study Results for the Robinsons River Salt ProjectNews · Aug 6, 2026
- AbCellera Biologics Inc (ABCL) (Q2 2026) Earnings Call Highlights: Strong Pipeline Progress and ...News · Aug 6, 2026
- AbCellera Biologics Q2 Earnings Call HighlightsNews · Aug 5, 2026
- Entrada Therapeutics Reports Second Quarter 2026 Financial ResultsNews · Aug 5, 2026
Headlines via Yahoo Finance and publishers — click through to read each story at its source.
Loading the live VRTX dashboard…